"We are on the verge of the first human studies"
Neuromodulation could provide therapeutic stimuli for a variety of disease patterns from depression to epilepsy and Alzheimer's. CorTec GmbH, based in Freiburg,...
Interview with Dr. Oliver Bärtl, Managing Director of CorTec GmbH